Targeting strategies and behavior change to combat the HIV epidemic in southern Africa

Papers of special note have been highlighted as: ▪ of interest ▪▪ of considerable interest

Bibliography

• 1  Schackman BR. Implementation science for the prevention and treatment of HIV/AIDS. J. Acquir. Immune Defic. Syndr.55(Suppl. 1),S27–S31 (2010).▪▪ Key article presenting the case for the developing discipline of implementation science in HIV prevention.
  MedlineGoogle Scholar
• 2  Mahy M, Stover J, Kiragu K et al. What will it take to achieve virtual elimination of mother-to-child transmission of HIV? An assessment of current progress and future needs. Sex. Trans. Infect.86(Suppl. 2),II48–II55 (2010).
  MedlineGoogle Scholar
• 3  Siegfried N, Muller M, Deeks JJ, Volmink J. Male circumcision for prevention of heterosexual acquisition of HIV in men. Cochrane Database Syst. Rev. (2), CD003362 (2009).▪ Cochrane review of effectiveness of male circumcision for HIV prevention.
  MedlineGoogle Scholar
• 4  WHO. Postexposure prophylaxis to prevent HIV infection. Joint WHO/ILO guidelines on postexposure prophylaxis (PEP) to prevent HIV infection. WHO, Switzerland (2007).
  Google Scholar
• 5  Grant RM, Lama JR, Anderson PL et al. Preexposure chemoprophylaxis for HIV prevention in men who sex with men. N. Engl. J. Med.363(27),2587–2599 (2010).▪ Report of a multi-site randomized controlled trial (RCT) of pre-exposure prophylaxis in men who have sex with men.
  Medline CASGoogle Scholar
• 6  Abdool KQ, Abdool Karim SS, Frohlich JA et al. Effectiveness and safety of tenofovir gel, an antiretroviral microbicide, for the prevention of HIV infection in women. Science329(5996),1168–1174 (2010).▪ Report of an RCT of an antiretroviral-based microbicide.
  MedlineGoogle Scholar
• 7  Weiss HA, Dickson KE, Agot K, Hankins CA. Male circumcision for HIV prevention: current research and programmatic issues. AIDS24(Suppl. 4),S61–S69 (2010).
  MedlineGoogle Scholar
• 8  Tanser F, Bärnighausen T, Cooke GS, Newell ML. Localized spatial clustering of HIV infections in a widely disseminated rural South African epidemic. Int. J. Epidemiol.38,1008–1016 (2009).
  MedlineGoogle Scholar
• 9  Camlin C, Hosegood V, Newell ML, McGrath N, Bärnighausen T, Snow RC. Gender, migration and HIV in rural KwaZulu-Natal, South Africa. PLoS One5(7),E11539 (2010).
  MedlineGoogle Scholar
• 10  Bärnighausen T, Tanser F, Hallett T, Newell ML. Prioritizing communities for HIV prevention in sub-Saharan Africa. AIDS Res. Human Retroviruses26(4),401–405 (2010).▪ Model for prioritizing prevention intervention scale-up.
  MedlineGoogle Scholar
• 11  Falnes EF, Moland KM, Tylleskar T, de Paoli MM, Msuya SE, Engebretsen IM. ‘It’s her responsibility’: partner involvement in prevention of mother to child transmission of HIV programmes, northern Tanzania. J. Int. AIDS Soc.14(1),21 (2011).
  MedlineGoogle Scholar
• 12  Parkhurst JO. Understanding the correlations between wealth, poverty and human immunodeficiency virus infection in African countries. Bull. World Health Organ.88(7),519–526 (2010).
  MedlineGoogle Scholar
• 13  Bolu OO, Allread V, Creek T et al. Approaches for scaling up human immunodeficiency virus testing and counseling in prevention of mother-to-child human immunodeficiency virus transmission settings in resource-limited countries. Am. J. Obstet. Gynecol.197(3 Suppl.),S83–S89 (2007).
  MedlineGoogle Scholar
• 14  Chersich MF, Rees HV, Scorgie F, Martin G. Enhancing global control of alcohol to reduce unsafe sex and HIV in sub-Saharan Africa. Global Health5,16 (2009).
  MedlineGoogle Scholar
• 15  Amon JJ, Kasambala T. Structural barriers and human rights related to HIV prevention and treatment in Zimbabwe. Glob. Public Health4,528–545 (2009).
  Medline CASGoogle Scholar
• 16  Stoneburner RL, Low-Beer D. Population-level HIV declines and behavioral risk avoidance in Uganda. Science304,714 (2004).▪ Review of the evidence to explain HIV decline in Uganda.
  Medline CASGoogle Scholar
• 17  Gregson S, Garnett GP, Nyamukapa CA et al. HIV decline associated with behavior change in eastern Zimbabwe. Science311,664–666 (2006).▪ Examination of behavior change evidence to explain HIV declines in Zimbabwe.
  Medline CASGoogle Scholar
• 18  Southern African Development Community (SADC). Expert think tank meeting on HIV prevention in high-prevalence countries in Southern Africa: report. Maseru, Lesotho. Gaborone: SADC 10–12 May (2006).
  Google Scholar
• 19  Shisana O, Rehle T, Simbayi L et al. South African National Prevalence, Incidence, Behaviour and Communication Survey, 2008. A Turning Tide Among Teenagers? HSRC Press, South Africa (2009).
  Google Scholar
• 20  Aral SO, Blanchard JF. Phase specific approaches to the epidemiology and prevention of sexually transmitted diseases. Sex. Transm. Infect.78(Suppl. 1),I1–I2 (2002).
  MedlineGoogle Scholar
• 21  Epstein H. AIDS and the irrational. Br. Med. J.337,A2638 (2008).
  MedlineGoogle Scholar
• 22  Lurie MN, Rosenthal S. Concurrent partnerships as a driver of the HIV Epidemic in sub-Saharan Africa? The evidence is limited. AIDS Behav.14,17–24 (2010).
  MedlineGoogle Scholar
• 23  Mah TL, Halperin DT. Concurrent sexual partnerships and the HIV epidemics in Africa: evidence to move forward. AIDS Behav.14,11–16 (2010).
  MedlineGoogle Scholar
• 24  Morris M. Barking up the Wrong Evidence Tree. Comment on Lurie & Rosenthal, Concurrent partnerships as a driver of the HIV epidemic in sub-Saharan Africa? The evidence is limited’. AIDS Behav.14,31–33 (2010).
  MedlineGoogle Scholar
• 25  Sawers L, Stillwaggon E. Concurrent sexual partnerships do not explain the HIV epidemics in Africa: a systematic review of the evidence. J. Int. AIDS Soc.13,34 (2010).▪▪ Key review article and synoposis of the state of the science.
  MedlineGoogle Scholar
• 26  Tanser F, Bärnighausen T, Hund L, Garnett G, Mcrath N, Newell M. The impact of concurrent sexual partnerships on the rate of new HIV infections in a high prevalence, rural South African population. Lancet (2011) (in press).▪▪ An empirically based challenge in the concurrency debate.
  MedlineGoogle Scholar
• 27  Halperin DT, Mugurungi O, Hallett TB et al. A surprising prevention success: why did the HIV epidemic decline in Zimbabwe? PLoS Med.8(2),E1000414 (2011).▪ Review of the evidence to explain HIV decline in Zimbabwe.
  MedlineGoogle Scholar
• 28  Cowan FM, Pascoe SJS, Langhaug LF et al. The Regai Dzive Shiri project: results of a randomized trial of an HIV prevention intervention for youth. AIDS24,2541–2552 (2010).▪ Report of RCT of youth intervention in Zimbabwe.
  MedlineGoogle Scholar
• 29  Michielsen K, Chersich MF, Luchters S et al. Effectiveness of HIV prevention for youth in sub-Saharan Africa: systematic review and meta-analysis of randomized and nonrandomized trials. AIDS24,1193–1202 (2010).▪ Critical review of the evidence of effectiveness of youth interventions in sub-Saharan Africa.
  MedlineGoogle Scholar
• 30  Harrison A, Newell ML, Imrie J, Hoddinott G. HIV prevention for South African youth: systematic review of the evidence for ‘What Works’. BMC Public Health10,102 (2010).
  MedlineGoogle Scholar
• 31  Chimbindi N, McGrath N, Herbst K et al. Socio-demographic determinants of condom use among sexually active young adults in rural KwaZulu-Natal, South Africa. Open AIDS J.4,88–95 (2010).
  MedlineGoogle Scholar
• 32  Han J, Bennush ML. Condom access in South African schools: law, policy and practice. PLoS Med.6(1),E1000006 (2009).
  Google Scholar
• 33  Gupta GR, Parkhurst JO, Ogden JA et al. Structural approaches to HIV prevention. Lancet372(9640),764–775 (2008).
  MedlineGoogle Scholar
• 34  Weber J, Tatoud R, Fidler S. Postexposure prophylaxis, preexposure prophylaxis or universal test and treat: the strategic use of antiretroviral drugs to prevent HIV acquisition and transmission. AIDS24(Suppl. 4),S27–S39 (2010).▪ Discussion of merits and challenges of biomedical HIV prevention interventions.
  Medline CASGoogle Scholar
• 35  WHO. Delivering HIV test results and messages for re-testing and counselling in adults. WHO, Switzerland (2008).
  Google Scholar
• 36  Shelton JD. Counselling and testing for HIV prevention Lancet372(9635),273–275 (2008).
  MedlineGoogle Scholar
• 37  Zuma T, Newell M-L, Mapumulo K, Dabis, F, Imrie J. ‘Testing gives us a chance to get encouraged and say let us stand up … then we will get help’: contrasting community representations of HIV testing in the context of treatment as prevention in rural north-eastern KwaZulu-Natal? South African AIDS Conference. Durban, South Africa, 7–10 June 2011.
  Google Scholar
• 38  Herman-Roloff A, Llewellyn E, Obiero W et al. Implementing voluntary medical male circumcision for HIV prevention in Nyanza Province, Kenya: lessons learned during the first year. PLoS One6(4),E18299 (2011).
  Medline CASGoogle Scholar
• 39  Granich RM, Gilks CF, Dye C, De Cock KM, Williams BG. Universal voluntary HIV testing with immediate antiretroviral therapy as a strategy for elimination of HIV transmission: a mathematical model. Lancet373,48–57 (2009).
  MedlineGoogle Scholar
• 40  Young SD, Hlavka Z, Modiba P et al. HIV-related stigma, social norms, and HIV testing in Soweto and Vulindlela, South Africa: National Institutes of Mental Health Project Accept (HPTN 043). J. AIDS55(5),620–624 (2011).
  Google Scholar
• 41  Mutevedzi P, Lessells R, Heller T, Bärnighausen T, Cooke G, Newell ML. Scale-up of a decentralised HIV treatment programme in rural KwaZulu-Natal, South Africa: does rapid expansion affect patient outcomes? Bull. World Health Org.88,593–600 (2010).
  MedlineGoogle Scholar
• 42  Brennan AT, Maskew M, Sanne I, Fox MP. The importance of clinic attendance in the first six months on antiretroviral treatment: a retrospective analysis at a large public sector HIV clinic in South Africa. J. Int. AIDS Soc.13,49 (2010).
  MedlineGoogle Scholar
• 43  Lessells RJ, Mutevedzi PC, Cooke GS, Newell ML. Retention in care for individuals not yet eligible for antiretroviral therapy: rural KwaZulu-Natal, South Africa. J. AIDS56(3),E79–E86 (2011).
  Medline CASGoogle Scholar
• 44  Chaiyachati K, Hirschhorn L, Tanser F, Newell ML, Bärnighausen T. Validating five questions on antiretroviral treatment adherence in a decentralized community-based ART program in South Africa. AIDS Patient Care STD (2011) (In Press).
  MedlineGoogle Scholar
• 45  Van Tam V, Pharris A, Thorson A et al. ‘It is not that I forget, it’s just that I don’t want other people to know’: barriers to and strategies for adherence to antiretroviral therapy among HIV patients in Northern Vietnam. AIDS Care23(2),139–145 (2011).
  MedlineGoogle Scholar
• 46  Mahajan AP, Sayles JN, Patel VA et al. Sigma in the HIV/AIDS epidemic: a review of the literature and recommendations for a way forward. AIDS22(Suppl. 2),S67–S79 (2008).
  MedlineGoogle Scholar
• 47  Foster SD, Nakamanya S, Kyomuhangi R et al. The experience of ‘medicine companions’ to support adherence to antiretroviral therapy: quantitative and qualitative data from a trial population in Uganda. AIDS Care22(Suppl. 1),35–43 (2010).
  MedlineGoogle Scholar
• 48  Roura M, Urassa M, Busza J et al. Scaling up stigma? The effects of antiretroviral roll-out on stigma and HIV testing. Early evidence from rural Tanzania. Sex. Transm. Infect.85(4),308–312 (2009).
  Medline CASGoogle Scholar
• 49  Gilbert L, Walker L. ‘My biggest fear was that people would reject me once they knew my status…’: stigma as experienced by patients in an HIV/AIDS clinic in Johannesburg, South Africa. Health Soc. Care Commun.18(2),139–146 (2010).
  MedlineGoogle Scholar
• 50  Sumartojo E, Carey JW, Doll LS, Gayle H. Targeted and general population interventions for HIV prevention: towards a comprehensive approach. AIDS11,1201–1209 (1997).
  Medline CASGoogle Scholar
• 51  Tanser F, Bärnighausen T, Newell M. Identification of localized clusters of high HIV incidence in a widely disseminated rural South African epidemic: a case for targeted intervention strategies. Presented at: The 18th Conference on Retroviruses and Opportunistic Infections (CROI). Boston, MA, USA, 27 February–2 March 2011.
  Google Scholar
• 52  WHO; UNAIDS. Guidelines for second generation HIV surveillance for HIV: the next decade. WHO, Switzerland (WHO/CDS/EDC/2000.05) (2000).
  Google Scholar
• 101  UNAIDS (the Joint United Nations Program on HIV/AIDS): AIDS Epidemic update. UNAIDS publications UNAIDS/07.27E/JC1322E (2010) www.unaids.org/en/media/unaids/contentassets/documents/unaidspublication/2010/20101123_globalreport_en.pdf (Accessed 20 February 2011)
  Google Scholar
• 102  Global HIV Prevention Working Group: Behaviour change and HIV prevention: (Re) onsiderations for the 21st century www.globalhivprevention.org/pdfs/PWG_behavior%20report_FINAL.pdf (Accessed 20 February 2011)
  Google Scholar
• 103  ANRS: Traiter toutes les personnes infectées par le VIH: un impact sur la pandémie? www.anrs.fr/Qui-sommes-nous/Actualites/1er-decembre-Journee-mondiale-de-lutte-contre-le-sida
  Google Scholar
• 104  WHO: Male circumcision quality assurance: a guide to enhancing the safety and quality of services (2008). http://whqlibdoc.who.int/publications/2008/9789241597319_eng.pdf (Accessed 20 February 2011)
  Google Scholar
• 105  AVERT: HIV & AIDS in South Africa www.avert.org/aidssouthafrica.htm (Accessed 20 February 2011)
  Google Scholar
• 106  South Africa.info. Zuma to launch new HIV/AIDS plan www.southafrica.info/news/hiv-230410.htm (Accessed 20 February 2011)
  Google Scholar
• 107  Project Accept Study Group. Project Accept: a Phase III randomized controlled trial of community mobilization, mobile testing, same-day results, and post-test support for HIV in sub-Saharan Africa and Thailand (HPTN 043): study protocol www.cbvct.med.ucla.edu/protocol.pdf (Accessed 20 February 2011)
  Google Scholar